Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.53 USD | -2.14% | +2.19% | +16.72% |
Financials (USD)
Sales 2024 * | 12.57M | Sales 2025 * | 94.02M | Capitalization | 3.14B |
---|---|---|---|---|---|
Net income 2024 * | -178M | Net income 2025 * | -134M | EV / Sales 2024 * | 182 x |
Net cash position 2024 * | 854M | Net cash position 2025 * | 663M | EV / Sales 2025 * | 26.4 x |
P/E ratio 2024 * |
-17.8
x | P/E ratio 2025 * |
-23.1
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.89% |
Latest transcript on IDEAYA Biosciences, Inc.
1 day | -2.14% | ||
1 week | +2.19% | ||
Current month | +2.16% | ||
1 month | +0.87% | ||
3 months | -11.88% | ||
6 months | +38.71% | ||
Current year | +16.72% |
Managers | Title | Age | Since |
---|---|---|---|
Yujiro Hata
FOU | Founder | 49 | 15-05-31 |
Andres Briseno
DFI | Director of Finance/CFO | 38 | 16-07-31 |
Michael White
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Terry Rosen
CHM | Chairman | 65 | 16-05-05 |
Wendy Yarno
BRD | Director/Board Member | 69 | 19-12-16 |
Catherine Mackey
BRD | Director/Board Member | 68 | 22-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.24% | 2 M€ | -.--% | ||
0.09% | 7 M€ | -.--% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 41.53 | -2.14% | 532,228 |
24-05-15 | 42.44 | +1.53% | 762,107 |
24-05-14 | 41.8 | +1.78% | 373,266 |
24-05-13 | 41.07 | -0.24% | 452,226 |
24-05-10 | 41.17 | +1.30% | 446,904 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.72% | 3.14B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+50.30% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- IDYA Stock